Literature DB >> 21126318

Activation, regulation, and inhibition of DYRK1A.

Walter Becker1, Wolfgang Sippl.   

Abstract

Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a protein kinase with diverse functions in neuronal development and adult brain physiology. Higher than normal levels of DYRK1A are associated with the pathology of neurodegenerative diseases and have been implicated in some neurobiological alterations of Down syndrome, such as mental retardation. It is therefore important to understand the molecular mechanisms that control the activity of DYRK1A. Here we review the current knowledge about the initial self-activation of DYRK1A by tyrosine autophosphorylation and propose that this mechanism presents an ancestral feature of the CMGC group of kinases. However, tyrosine phosphorylation does not appear to regulate the enzymatic activity of DYRK1A. Control of DYRK1A may take place on the level of gene expression, interaction with regulatory proteins and regulated nuclear translocation. Finally, we compare the properties of small molecule inhibitors that target DYRK1A and evaluate their potential application and limitations. The β-carboline alkaloid harmine is currently the most selective and potent inhibitor of DYRK1A and has proven very useful in cellular assays.
© 2010 The Authors Journal compilation © 2010 FEBS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21126318     DOI: 10.1111/j.1742-4658.2010.07956.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  70 in total

1.  DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model.

Authors:  Nobuhiro Kurabayashi; Minh Dang Nguyen; Kamon Sanada
Journal:  EMBO Rep       Date:  2015-09-15       Impact factor: 8.807

Review 2.  Banisteriopsis caapi, a Forgotten Potential Therapy for Parkinson's Disease?

Authors:  Atbin Djamshidian; Sabine Bernschneider-Reif; Werner Poewe; Andrew J Lees
Journal:  Mov Disord Clin Pract       Date:  2015-10-06

3.  Design and synthesis of conformationally constraint Dyrk1A inhibitors by creating an intramolecular H-bond involving a benzothiazole core.

Authors:  Mohamed Salah; Mohammad Abdel-Halim; Matthias Engel
Journal:  Medchemcomm       Date:  2018-05-28       Impact factor: 3.597

4.  Harmine treatment enhances short-term memory in old rats: Dissociation of cognition and the ability to perform the procedural requirements of maze testing.

Authors:  Sarah E Mennenga; Julia E Gerson; Travis Dunckley; Heather A Bimonte-Nelson
Journal:  Physiol Behav       Date:  2014-09-22

5.  DYRK1A interacts with histone acetyl transferase p300 and CBP and localizes to enhancers.

Authors:  Shanshan Li; Chu Xu; Yinkun Fu; Pin-Ji Lei; Yanhua Yao; Wanli Yang; Ying Zhang; Michael P Washburn; Laurence Florens; Manish Jaiswal; Min Wu; Man Mohan
Journal:  Nucleic Acids Res       Date:  2018-11-30       Impact factor: 16.971

6.  Transient expression of Mnb/Dyrk1a couples cell cycle exit and differentiation of neuronal precursors by inducing p27KIP1 expression and suppressing NOTCH signaling.

Authors:  Barbara Hämmerle; Edgar Ulin; Jordi Guimera; Walter Becker; François Guillemot; Francisco J Tejedor
Journal:  Development       Date:  2011-06       Impact factor: 6.868

7.  Effects of Y361-auto-phosphorylation on structural plasticity of the HIPK2 kinase domain.

Authors:  Antonella Scaglione; Laura Monteonofrio; Giacomo Parisi; Cristina Cecchetti; Francesca Siepi; Cinzia Rinaldo; Alessandra Giorgi; Daniela Verzili; Carlotta Zamparelli; Carmelinda Savino; Silvia Soddu; Beatrice Vallone; Linda Celeste Montemiglio
Journal:  Protein Sci       Date:  2017-12-28       Impact factor: 6.725

8.  Minibrain and Wings apart control organ growth and tissue patterning through down-regulation of Capicua.

Authors:  Liu Yang; Sayantanee Paul; Kenneth G Trieu; Lucas G Dent; Francesca Froldi; Marta Forés; Kaitlyn Webster; Kellee R Siegfried; Shu Kondo; Kieran Harvey; Louise Cheng; Gerardo Jiménez; Stanislav Y Shvartsman; Alexey Veraksa
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

9.  Comparative analysis of the DYRK1A-SRSF6-TNNT2 pathway in myocardial tissue from individuals with and without Down syndrome.

Authors:  Adolfo Quiñones-Lombraña; Javier G Blanco
Journal:  Exp Mol Pathol       Date:  2019-06-12       Impact factor: 3.362

10.  Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I: A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE.

Authors:  Nana Jin; Xiaomin Yin; Jianlan Gu; Xinhua Zhang; Jianhua Shi; Wei Qian; Yuhua Ji; Maohong Cao; Xiaosong Gu; Fei Ding; Khalid Iqbal; Cheng-Xin Gong; Fei Liu
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.